Latest Breaking News On - நரேந்திர வர்தே - Page 1 : comparemela.com

Mumbai (Maharashtra) [India], April 19 (ANI/NewsVoir): Roche Diagnostics India launched its Quantitative antibody test- Elecsys Anti SARS CoV-2 S in January this year. The test since then has now been widely used in government and private hospitals and labs in various parts across the country. Roche Elecsys Anti SARS CoV-2 S test measures antibodies that could help detect a past natural infection or body s immune response to the vaccine. Roche Elecsys SARS CoV-2 S quantitative antibody test detects and quantifies antibodies in serum or plasma against the spike protein present on the surface of SARS CoV-2 virus. Spike protein is a common target for neutralizing antibodies. These type of antibodies prevent the virus from entering human cells thus protecting an individual. Hence, most COVID-19 vaccines contain the spike protein or at least a component of it so as to be able to produce an immune response in the form of antibodies and immune cells against it. The antibody immune respons

West bengalTamil naduPranav desaiNarendra vardeSmita juvvadiRoche elecsysArjun ananthLaboratory medicineInternational standardDesai metropolis health servicesRoche diagnostics indiaManaging directorTenet diagnosticsHitech diagnosticsDiagnostics indiaமேற்கு பெங்கல்